Marinomed Biotech AG (FRA:93Z)

Marinomed Biotech AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	33	27	44	85	130	175
Market Cap Growth	22.43%	-39.87%	-47.78%	-34.78%	-25.67%	19.23%
Enterprise Value	42	47	63	98	140	175
Last Close Price	16.95	15.30	29.90	56.20	87.20	115.00
PS Ratio	3.35	5.57	4.72	7.23	11.20	21.57
PB Ratio	-6.01	-1.02	-3.52	-20.43	680.53	32.71
P/TBV Ratio	-	-	-	-	8983.04	33.95
EV/Sales Ratio	4.31	9.72	6.70	8.38	12.06	21.54
Debt / Equity Ratio	-2.01	-1.12	-1.71	-5.44	82.54	2.39
Net Debt / Equity Ratio	-1.73	-1.05	-1.51	-3.48	52.23	0.67
Net Debt / EBITDA Ratio	-6.01	-4.19	-3.42	-2.95	-1.89	-0.53
Net Debt / FCF Ratio	-11.79	-11.49	-5.14	-2.66	-1.73	-0.33
Asset Turnover	1.03	0.47	0.54	0.54	0.52	0.38
Inventory Turnover	7.96	5.28	6.59	7.26	10.68	17.43
Quick Ratio	0.68	0.08	0.55	1.90	1.77	2.57
Current Ratio	0.74	0.10	0.66	2.40	2.14	2.75
Return on Equity (ROE)	-	-	-	-	-212.34%	-74.09%
Return on Assets (ROA)	-12.75%	-42.55%	-21.70%	-15.14%	-15.78%	-20.28%
Return on Capital Employed (ROCE)	-53.70%	30.00%	-219.80%	-32.40%	-36.90%	-39.00%
Earnings Yield	27.92%	-57.79%	-14.35%	-7.53%	-4.52%	-3.43%
FCF Yield	-	-9.00%	-8.34%	-6.39%	-4.44%	-6.19%
Buyback Yield / Dilution	-17.17%	-17.14%	-1.29%	-1.56%	-0.31%	-3.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.